RxDoctor Payments Data

Craig Moergen

Psychiatric/Mental Health · Wentzville, MONPI 1174724918

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 135 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,522 and has fallen 98.7% since, to $20 in 2025.

$2,225in general payments, 2019–2025

Across 135 payments — averaging $16.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$533
  • Sunovion Pharmaceuticals Inc.$463
  • Johnson & Johnson$223
  • Vanda Pharmaceuticals Inc.$196
  • Alkermes, Inc.$163
  • Otsuka America Pharmaceutical, Inc.$133
  • plus $514 from 8 others

What the payments were for

  • Food & beverage$2,225100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,225 in reported general payments places this provider in the 70th percentile of 565 psychiatric/mental health providers in Missouri.

See all psychiatric/mental health providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate61$213,740
Abilify MaintenaAripiprazole58$164,448
RexultiBrexpiprazole71$107,013
VraylarCariprazine Hcl67$94,381
CaplytaLumateperone Tosylate43$70,664
TrintellixVortioxetine Hydrobromide113$53,105
Lurasidone Hcl144$22,088
Hydroxyzine Hcl341$8,272
Clomipramine Hcl33$6,905
Vilazodone Hcl58$5,617
Clozapine60$5,284
Bupropion XlBupropion Hcl157$4,807
Aripiprazole158$3,677
Quetiapine Fumarate187$3,055
Buspirone Hcl174$3,036

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$133$271,461129 claims
Johnson & JohnsonInvega Sustenna$223$213,74061 claims
AbbVieVraylar$533$94,38167 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$102$70,66443 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$20$53,105113 claims
Teva Pharmaceuticals USA, Inc.Loxapine$70$88118 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 565 psychiatric/mental health providers in Missouri.

Other psychiatric/mental health in Wentzville

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →